After 30 years of working on AIDS research, an American lab has developed new vaccine candidates that appear promising enough to consider advancing into clinical trials within the next two years.
After 30 years of working on AIDS research, an American lab has developed new vaccine candidates that appear promising enough to consider advancing into clinical trials within the next two years.